The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 360:1360-1361 March 26, 2009 Number 13
NextNext

Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Meigs, J. B.
-Related Article
by Lyssenko, V.
-PubMed Citation
To the Editor: With the availability of strong evidence that prevention of type 2 diabetes among people at high risk for the disease might be feasible,1 the interest in identifying people at high risk who might benefit from interventions is topical. Using 28 years of follow-up data from the Framingham Offspring Study, Meigs et al. (Nov. 20 issue)2 found that a combination of simple clinical measures (age, sex, presence or absence of a family history, body-mass index, fasting glucose level, systolic blood pressure, high-density lipoprotein cholesterol level, and triglyceride level) can predict the incidence of future type 2 diabetes with . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.